Oestrogen receptor analysis is widely used in the management of breast and endometrial cancers. The main interest in oestrogen receptor content is because ofits ability to predict the response to endocrine treatment' and its possible value as an overall prognostic indicator" in breast and endometrial cancers.
Various biochemical analyses have been used routinely for oestrogen receptor quantification, 4 Positive staining was restricted to the nuclei of epithelial cells in the breast lesions; in sections from the uterus positive staining was observed in the nuclei of both epithelial and stromal cells. The proportion of positive cells ranged from 0-90%. Considerable heterogeneity was observed with respect to the intensity of nuclear staining in individual cells within the same section. Normal cellular elements showed nuclear oestrogen receptor staining in sections from both oestrogen receptor positive and oestrogen receptor negative tumours, and served as internal controls when present. There was no staining of cell nuclei in the negative control slides. Intraobserver variation is shown in fig 2. This plot shows the HSCORE generated in the first and second review ofthe slides by observer I. There was a high correlation between the first and second review (r = 0 97; p < 0.0001). Interobserver variation is shown in fig 3 . This plot shows the HSCORE generated in the first review by observer I with the second observer. The graph shows a close correlation with an r value of 0-95 (p < 0.0001).
COMPARISON OF ENZYME IMMUNOASSAY WITH HISTOCHEMICAL OESTROGEN RECEPTOR ANALYSES
The histochemical score agreed with the enzyme immunoassay in 51 of 57 cases (89%) ( The overall sensitivity and spec present study was 88% and 93%,:
This agrees with the findings studies. 
